← Master Registry

Published peptide research references

Neuromedin U

Governed registry record

2 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. The neuropeptide NMU amplifies ILC2-driven allergic lung inflammation.

    DOI: 10.1038/nature24029

    Source identity and connection checked by Codex (AI).

  2. The neuropeptide neuromedin U stimulates innate lymphoid cells and type 2 inflammation.

    DOI: 10.1038/nature23676

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Malendowicz LK
  • Rucinski M
  • Klose CSN
  • Mahlakõiv T
  • Moeller JB
  • Rankin LC
  • Flamar AL
  • Kabata H
  • Monticelli LA
  • Moriyama S
  • Putzel GG
  • Rakhilin N
  • Shen X
  • Kostenis E
  • König GM
  • Senda T
  • Carpenter D
  • Farber DL
  • Artis D
  • Wallrapp A
  • Riesenfeld SJ
  • Burkett PR
  • Abdulnour RE
  • Nyman J
  • Dionne D
  • Hofree M
  • Cuoco MS
  • Rodman C
  • Farouq D
  • Haas BJ
  • Tickle TL
  • Trombetta JJ
  • Baral P
  • Rozenblatt-Rosen O
  • Chiu IM
  • Levy BD
  • Kowalczyk MS
  • Regev A
  • Kuchroo VK
  • Li Y
  • Liu S
  • Zhou K
  • Wang Y
  • Chen Y
  • Hu W
  • Li S
  • Li H
  • Wang Q
  • He D
  • Xu H